微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | -9.53% | 49.76% | -112.62% | 45/47 | 2.33% | 澳洋健康 | 34.16% | 行业排名> |
| 2022-12-31 | 75.53% | 110.41% | 243% | 1/47 | -0.32% | 澳洋健康 | 30.56% | 行业排名> |
| 2022-09-30 | -52.82% | 94.41% | -238.82% | 44/47 | 10.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2022-06-30 | 38.05% | 111.59% | 300.58% | 2/47 | 6.38% | 澳洋健康 | 39.54% | 行业排名> |
| 2022-03-31 | -18.97% | 66.81% | 97.39% | 42/47 | 2.74% | 澳洋健康 | 61.84% | 行业排名> |
| 2021-12-31 | -725.51% | -454.08% | 23.17% | 46/47 | -24.3% | 澳洋健康 | 48.34% | 行业排名> |
| 2021-09-30 | -944.3% | -26425.28% | -187.7% | 38/47 | -22.68% | 澳洋健康 | 58.19% | 行业排名> |
| 2021-06-30 | -328.22% | -1423.77% | -474.21% | 45/47 | -5.51% | *ST宜康 | 75.53% | 行业排名> |
| 2021-03-31 | -57.16% | -6181.32% | 56.35% | 32/47 | 0.11% | 博腾股份 | 39.77% | 行业排名> |
| 2020-12-31 | -130.94% | -24.88% | -3578.09% | 46/47 | 7.9% | 睿智医药 | 41.16% | 行业排名> |
| 2020-09-30 | -3.56% | -3336.36% | 83.47% | 26/47 | 8.05% | 澳洋健康 | 51.68% | 行业排名> |
| 2020-06-30 | -21.54% | -43180% | -2267.03% | 37/47 | 2.07% | 澳洋健康 | 40.93% | 行业排名> |
| 2020-03-31 | -0.91% | -142.33% | 99.13% | 21/47 | -0.31% | 金域医学 | 43.58% | 行业排名> |
| 2019-12-31 | -104.85% | -1895.38% | -95418.18% | 44/47 | 66.41% | 金域医学 | 35.41% | 行业排名> |
| 2019-09-30 | 0.11% | -98.74% | 120% | 24/47 | 10.92% | 阳光诺和 | 26.2% | 行业排名> |
| 2019-06-30 | 0.05% | -99.18% | -97.67% | 26/47 | 5.77% | 金域医学 | 13.23% | 行业排名> |
| 2019-03-31 | 2.15% | -48.44% | -63.18% | 12/47 | 3.67% | 万邦医药 | 52.05% | 行业排名> |
| 2018-12-31 | 5.84% | -15.61% | -32.95% | 27/47 | -3.17% | 华大基因 | 48.52% | 行业排名> |
| 2018-09-30 | 8.71% | 42.09% | 42.55% | 15/47 | 3.01% | 华大基因 | 31.24% | 行业排名> |
| 2018-06-30 | 6.11% | 44.1% | 46.52% | 12/47 | 1.83% | 阳光诺和 | 13.99% | 行业排名> |
| 2018-03-31 | 4.17% | 117.19% | -39.74% | 3/47 | 0.59% | 南华生物 | 2848.07% | 行业排名> |
| 2017-12-31 | 6.92% | -81.48% | 12.89% | 22/47 | 1.76% | 南华生物 | 98.98% | 行业排名> |
| 2017-09-30 | 6.13% | -83.36% | 44.58% | 14/47 | 8.72% | 南华生物 | 82.46% | 行业排名> |
| 2017-06-30 | 4.24% | -88.31% | 120.83% | 14/47 | 62.38% | 南华生物 | 48.41% | 行业排名> |
| 2017-03-31 | 1.92% | -94.77% | -94.86% | 12/47 | -5.85% | 万邦医药 | 106.72% | 行业排名> |
| 2016-12-31 | 37.36% | 952.39% | 1.41% | 2/47 | 21.24% | 国际医学 | 46.66% | 行业排名> |
| 2016-09-30 | 36.84% | 61300% | 1.54% | 1/47 | 7.9% | 普蕊斯 | 22.99% | 行业排名> |
| 2016-06-30 | 36.28% | 90600% | -1.25% | 2/47 | 4.92% | 通策医疗 | 6.02% | 行业排名> |
| 2016-03-31 | 36.74% | 16600% | 934.93% | 1/47 | 3.43% | 普蕊斯 | 58.68% | 行业排名> |
| 2015-12-31 | 3.55% | 6.93% | 5816.67% | 22/47 | 22.9% | 爱尔眼科 | 20.87% | 行业排名> |
| 2015-09-30 | 0.06% | -40% | 50% | 15/47 | 4.77% | 南华生物 | 1666.98% | 行业排名> |
| 2015-06-30 | 0.04% | 110.81% | -81.82% | 14/47 | -32.72% | 爱尔眼科 | 5.19% | 行业排名> |
| 2015-03-31 | 0.22% | 133.85% | -93.37% | 11/47 | -6.25% | 南华生物 | 383.03% | 行业排名> |
| 2014-12-31 | 3.32% | -73.31% | 3220% | 15/47 | -15.57% | -- | -- | 行业排名> |
| 2014-09-30 | 0.1% | -94.38% | 127.03% | 13/47 | -112.78% | -- | -- | 行业排名> |
| 2014-06-30 | -0.37% | -124.34% | 43.08% | 13/47 | -95.07% | -- | -- | 行业排名> |
| 2014-03-31 | -0.65% | -750% | -105.23% | 13/47 | -8.05% | -- | -- | 行业排名> |
| 2013-12-31 | 12.44% | 4684.62% | 598.88% | 13/47 | 6.28% | -- | -- | 行业排名> |
| 2013-09-30 | 1.78% | 456.25% | 17.11% | 12/47 | 5.69% | -- | -- | 行业排名> |
| 2013-06-30 | 1.52% | 280% | 1420% | 14/47 | 6.67% | -- | -- | 行业排名> |
| 2013-03-31 | 0.1% | 25% | -61.54% | 12/47 | 1.32% | -- | -- | 行业排名> |